Resipime-T 1000mg/125mg Injection
Marketer
Rescuers Life Sciences Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Resipime-T 1000mg/125mg Injection
The dual-antibiotic injection, Resipime-T 1000mg/125mg, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical practitioner; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Severe or persistent side effects warrant immediate medical attention. Allergic responses (rash, itching, swelling, respiratory distress) necessitate prompt emergency care. Prior to commencing treatment, inform your physician of all current medications and pre-existing health conditions. This is particularly important for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Primary Ingredients of Resipime-T 1000mg/125mg Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Resipime-T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Resipime-T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Resipime-T 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Resipime-T 1000mg/125mg Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
How Resipime-T 1000mg/125mg Injection works:
Resipime-T Injection (1000mg cefepime/125mg tazobactam) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes (beta-lactamases) that would otherwise deactivate cefepime. This synergistic effect broadens cefepime's antibacterial spectrum and overcomes bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Resipime-T 1000mg/125mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Resipime-T (1000mg/125mg) is typically deemed safe for use in pregnant individuals. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Resipime-T (1000mg/125mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Following administration of Resipime-T 1000mg/125mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
The antibiotic Resipime-T 1000mg/125mg injection requires careful administration in individuals with impaired renal function. Dosage modification for Resipime-T 1000mg/125mg injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Resipime-T 1000mg/125mg Injection in patients with hepatic impairment is likely safe, with existing evidence indicating that dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Resipime-T 1000mg/125mg Injection :
Should you forget a scheduled dose of Resipime-T 1000mg/125mg Injection, seek immediate medical advice.
Facts to Know About Resipime-T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently